Cat.#: ASSD-137
| Description | Chemokine CCR2 covalent negative allosteric modulator (NAM) binds intracellularly and forms a covalent bond with one of three proximal cysteine residues of CCR2. Apparent pKi values at CCR2 are 8.7 and 9.2 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 2-[[4-[4-Chloro-2-[[4-chloro-3-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]benzoyl]amino]ethyl thiocyanate |
| Molecule Weight | 590.4 |
| Molecular formula | C23H16Cl2F3N3O4S2 |
| PubChem identifier | 162666730 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
| ASSD-183 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) | 100 mg | inquiry |
| ASSD-150 | Luminol (AC150) | 1 g | inquiry |
| ASSD-145 | Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) | 1 mL | inquiry |
| ASSD-216 | K 114 (AC216) | 10 mg, 50 mg | inquiry |
| ASSD-205 | Acridinium C2 NHS Ester (AC205) | 5 mg, 10 mg | inquiry |
| ASSD-119 | Fluorescent adenosine agonist [NECA] (AC119) | 500 μg | inquiry |
| ASSD-147 | Rhodamine phalloidin-TRITC (AC147) | 300 tests, 100μg | inquiry |
| ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
| ASSD-176 | Rhodamine B isothiocyanate (AC176) | 100 mg, 500 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.